Geoffrey Harris and EJE prize lectures

Visit the exhibition today

Novartis gets EU approval for Cushing's drug (Reuters, 25 April 2012)

25 Apr 2012

Novartis reports that the European Commission has approved Signifor (pasireotide) for patients with Cushing's disease for whom surgery is not an option or for whom surgery has failed.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read